Polomar Health Services (PMHS) FCF Margin (2022 - 2026)
Polomar Health Services (PMHS) posted FCF Margin of 7.94% for Q2 2026, up 132.11% on a QoQ basis from 3.42% in Q1 2026, and up 344084.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
Polomar Health Services (PMHS) FCF Margin (2022 - 2026) Analysis & Trends
Polomar Health Services has reported FCF Margin for 5 years, with the latest figure at 7.94% in Q2 2026.
- On a quarterly basis, FCF Margin rose 344084.0% year-over-year to 7.94% in Q2 2026; TTM through Jun 2026 was 0.22%, a 208943.0% increase from a year earlier, with the FY2025 full-year figure at 61.09%, up 182705.0% from the prior year.
- FCF Margin was 7.94% for Q2 2026 at Polomar Health Services, up from 3.42% in the prior quarter.
- The five-year high for FCF Margin was 30.06% in Q4 2025, with the low at 5722.2% in Q3 2025.
- Average FCF Margin over 5 years is 1464.69%, with a median of 1138.34% recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: FCF Margin sank 264796 bps in 2025, then surged 344084 bps in 2026.
- Over 5 years, FCF Margin stood at 52.04% in 2022, then slumped by 2346 bps to 1273.23% in 2023, then retreated by 19 bps to 1509.32% in 2024, then soared by 102 bps to 30.06% in 2025, then sank by 74 bps to 7.94% in 2026.
- The last three FCF Margin figures came in at 7.94% (Q2 2026), 3.42% (Q1 2026), and 30.06% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 7.41% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 8.76% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.10% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -6.52% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 20.79% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 20.15% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 14.76% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 23.24% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 7.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.94% |
| Mar 31, 2026 | 3.42% |
| Dec 31, 2025 | 30.06% |
| Sep 30, 2025 | -5,722.20% |
| Jun 30, 2025 | -3,432.91% |
| Mar 31, 2025 | -1,003.46% |
| Dec 31, 2024 | -1,509.32% |
| Sep 30, 2024 | -3,074.24% |
| Jun 30, 2024 | -1,977.80% |
| Mar 31, 2024 | -1,515.22% |
| Dec 31, 2023 | -1,273.23% |
| Sep 30, 2023 | -697.87% |
| Dec 31, 2022 | -52.04% |
| Sep 30, 2022 | -288.82% |